About Us
Utilize groundbreaking clinical development strategies to advance new treatment options with the mission of improved patient outcomes.
We advance the development of new medicines for high unmet need populations by:
Harnessing clinical-stage drug candidates that have stalled in their development
Utilizing data from patients treated to date to identify responder subpopulation(s)
Achieve operational efficiencies for continued development, ensuring a viable business case for our investors
Our initial focus is on oncology, given the high unmet need, availability of drug candidates, and our past experience.